Download Sample
Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....
Arteriovenous Fistula Treatment Market: By Treatment, By Type, and Region Forecast 2020-2031
Arteriovenous Fistula Treatment Market: By Treatment, By Type, and Region Forecast 2020-2031
Arteriovenous Fistula Treatment Market size was valued at US$ 487.37 million in 2024 and is expected to reach US$ 755.38 million by 2031, growing at a significant CAGR of 6.5% from 2025-2031. An arteriovenous fistula is an abnormal connection or passageway between an artery and a vein that may be congenital, surgically created for hemodialysis treatments, or acquired due to a pathological process, such as trauma or erosion of an aortic aneurysm. Based on the treatment type, Transcatheter embolization is anticipated to dominate the market share over the forecast period.
According to the American Heart Association, the crude incidence rates between 2009 and 2019 were 2.040 per 1,00,000 person-years for all arteriovenous fistulas. The growing awareness and development of new treatment methods will act as the growth drivers for the market, whereas the lack of awareness regarding arteriovenous fistula treatment might have a negative impact on the market. The limited treatment methods and the highly affected population due to the disease are huge opportunities for the growth of the market.
Study Period
2025-2031Base Year
2024CAGR
6.5%Largest Market
North-AmericaFastest Growing Market
Asia-Pacific
The market is expected to expand as key players in the market are investing largely in new treatment methods such as photodynamic therapy, antiangiogenic therapy, and other sclerotherapy methods. Furthermore, there have been growing FDA approvals for noninvasive devices for arteriovenous fistula creation. Thus, the growing geriatric population, increasing prevalence of end-stage renal disease, favorable reimbursement policies, and rising healthcare expenditure will drive the market growth over the forecast period.
The market has been segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. During a 10-year study period done by the American Heart Association, the crude incidence rates for cerebral arteriovenous malformations (CAVMs) was 0.805, for intracranial dural arteriovenous fistulas (DAVFs) WAS 1.044, and 0.177 for (spinal arteriovenous fistulas) SAVs. According to a research report, the rate of arteriovenous fistula has the highest rates in the Northeast and the lowest in the Southeast of the USA.
The North America Arteriovenous Fistula Treatment market is expected to dominate the market over the forecast period, due to the successful measures taken by the US government to provide the market with novel therapies for arteriovenous fistula, and also the presence of leading pharmaceutical players placed in the region have been positively impacting the market growth. Moreover, owing to the rising awareness of fistula treatment in the Europe region, the European market is also expected to witness growth over the forecast period.
Latin America
Europe
Asia Pacific
Middle East
North America
|
Report Benchmarks |
Details |
|
Report Study Period |
2025-2031 |
|
Market Size in 2024 |
US$ 487.37 million |
|
Market Size in 2031 |
US$ 755.38 million |
|
Market CAGR |
6.5% |
|
By Treatment Type |
|
|
By Type |
|
|
By Region |
|
Download Free Sample Report
The arteriovenous fistula treatment market size was valued at US$ 487.37 million in 2024 and is projected to grow at a CAGR of 6.5% from 2025-2031.
The limited treatment methods and the highly affected population due to the disease are the key opportunities for the market.
The growing awareness and development of new treatment methods are the growth drivers in the market.
Becton Dickinson, Medtronic, Cook Medical, Teleflex Incorporated, Fresenius Medical Care AG & Co. KGaA, NxStage Medical, Poly Medicure Limited, and Braun Melsungen AG are a few companies operating in the market.
| 1.Executive Summary |
| 2.Global Arteriovenous Fistula Treatment Market Introduction |
| 2.1.Global Arteriovenous Fistula Treatment Market - Taxonomy |
| 2.2.Global Arteriovenous Fistula Treatment Market - Definitions |
| 2.2.1.Treatment Type |
| 2.2.2.Type |
| 2.2.3.Geography |
| 2.2.4.Region |
| 3.Global Arteriovenous Fistula Treatment Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Product Landscape |
| 3.6. New Product Launches |
| 3.7. Impact of COVID 19 on Market |
| 4.Global Arteriovenous Fistula Treatment Market Analysis, 2020 - 2024 and Forecast 2025 - 2031 |
| 4.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5.Global Arteriovenous Fistula Treatment Market By Treatment Type, 2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 5.1. Drugs |
| 5.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. Transcatheter Embolization |
| 5.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 5.3. Ultrasound-guided Compression |
| 5.3.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.3.3. Market Opportunity Analysis |
| 5.4. Surgery |
| 5.4.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.4.3. Market Opportunity Analysis |
| 6.Global Arteriovenous Fistula Treatment Market By Type, 2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 6.1. Arteriovenous Fistulas |
| 6.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Dural |
| 6.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 6.3. Peripheral |
| 6.3.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.3.3. Market Opportunity Analysis |
| 6.4. Pial or Cerebral |
| 6.4.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.4.3. Market Opportunity Analysis |
| 6.5. Other Fistula Types |
| 6.5.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 6.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.5.3. Market Opportunity Analysis |
| 7.Global Arteriovenous Fistula Treatment Market By Geography, 2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 7.1. North America |
| 7.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Europe |
| 7.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 7.3. The Asia Pacific |
| 7.3.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.3.3. Market Opportunity Analysis |
| 7.4. Latin America |
| 7.4.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.4.3. Market Opportunity Analysis |
| 7.5. MEA |
| 7.5.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 7.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.5.3. Market Opportunity Analysis |
| 7.6. Rest of MEA |
| 7.6.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 7.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.6.3. Market Opportunity Analysis |
| 8.Global Arteriovenous Fistula Treatment Market By Region, 2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 8.1. North America |
| 8.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.1.3. Market Opportunity Analysis |
| 8.2. Europe |
| 8.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.2.3. Market Opportunity Analysis |
| 8.3. Asia Pacific (APAC) |
| 8.3.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.3.3. Market Opportunity Analysis |
| 8.4. Middle East and Africa (MEA) |
| 8.4.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.4.3. Market Opportunity Analysis |
| 8.5. Latin America |
| 8.5.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.5.3. Market Opportunity Analysis |
| 9.North America Arteriovenous Fistula Treatment Market ,2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 9.1. Treatment Type Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.1.1.Drugs |
| 9.1.2.Transcatheter Embolization |
| 9.1.3.Ultrasound-guided Compression |
| 9.1.4.Surgery |
| 9.2. Type Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.2.1.Arteriovenous Fistulas |
| 9.2.2.Dural |
| 9.2.3.Peripheral |
| 9.2.4.Pial or Cerebral |
| 9.2.5.Other Fistula Types |
| 9.3. Geography Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.3.1.North America |
| 9.3.2.Europe |
| 9.3.3.The Asia Pacific |
| 9.3.4.Latin America |
| 9.3.5.MEA |
| 9.3.6.Rest of MEA |
| 9.4. Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.4.1.United States of America (USA) |
| 9.4.2.Canada |
| 10.Europe Arteriovenous Fistula Treatment Market ,2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 10.1. Treatment Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1.Drugs |
| 10.1.2.Transcatheter Embolization |
| 10.1.3.Ultrasound-guided Compression |
| 10.1.4.Surgery |
| 10.2. Type Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.2.1.Arteriovenous Fistulas |
| 10.2.2.Dural |
| 10.2.3.Peripheral |
| 10.2.4.Pial or Cerebral |
| 10.2.5.Other Fistula Types |
| 10.3. Geography Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.3.1.North America |
| 10.3.2.Europe |
| 10.3.3.The Asia Pacific |
| 10.3.4.Latin America |
| 10.3.5.MEA |
| 10.3.6.Rest of MEA |
| 10.4. Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.4.1.Germany |
| 10.4.2.France |
| 10.4.3.Italy |
| 10.4.4.United Kingdom (UK) |
| 10.4.5.Spain |
| 11.Asia Pacific (APAC) Arteriovenous Fistula Treatment Market ,2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 11.1. Treatment Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1.Drugs |
| 11.1.2.Transcatheter Embolization |
| 11.1.3.Ultrasound-guided Compression |
| 11.1.4.Surgery |
| 11.2. Type Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.2.1.Arteriovenous Fistulas |
| 11.2.2.Dural |
| 11.2.3.Peripheral |
| 11.2.4.Pial or Cerebral |
| 11.2.5.Other Fistula Types |
| 11.3. Geography Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.3.1.North America |
| 11.3.2.Europe |
| 11.3.3.The Asia Pacific |
| 11.3.4.Latin America |
| 11.3.5.MEA |
| 11.3.6.Rest of MEA |
| 11.4. Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.4.1.China |
| 11.4.2.India |
| 11.4.3.Australia and New Zealand (ANZ) |
| 11.4.4.Japan |
| 11.4.5.Rest of APAC |
| 12.Middle East and Africa (MEA) Arteriovenous Fistula Treatment Market ,2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 12.1. Treatment Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.1.1.Drugs |
| 12.1.2.Transcatheter Embolization |
| 12.1.3.Ultrasound-guided Compression |
| 12.1.4.Surgery |
| 12.2. Type Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.2.1.Arteriovenous Fistulas |
| 12.2.2.Dural |
| 12.2.3.Peripheral |
| 12.2.4.Pial or Cerebral |
| 12.2.5.Other Fistula Types |
| 12.3. Geography Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.3.1.North America |
| 12.3.2.Europe |
| 12.3.3.The Asia Pacific |
| 12.3.4.Latin America |
| 12.3.5.MEA |
| 12.3.6.Rest of MEA |
| 12.4. Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.4.1.GCC Countries |
| 12.4.2.South Africa |
| 12.4.3.Rest of MEA |
| 13.Latin America Arteriovenous Fistula Treatment Market ,2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 13.1. Treatment Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.1.1.Drugs |
| 13.1.2.Transcatheter Embolization |
| 13.1.3.Ultrasound-guided Compression |
| 13.1.4.Surgery |
| 13.2. Type Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.2.1.Arteriovenous Fistulas |
| 13.2.2.Dural |
| 13.2.3.Peripheral |
| 13.2.4.Pial or Cerebral |
| 13.2.5.Other Fistula Types |
| 13.3. Geography Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.3.1.North America |
| 13.3.2.Europe |
| 13.3.3.The Asia Pacific |
| 13.3.4.Latin America |
| 13.3.5.MEA |
| 13.3.6.Rest of MEA |
| 13.4. Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.4.1.Brazil |
| 13.4.2.Mexico |
| 13.4.3.Rest of LA |
| 14. Competition Landscape |
| 14.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
| 14.2.1.Becton Dickinson |
| 14.2.2.Medtronic |
| 14.2.3.Cook Medical |
| 14.2.4.Teleflex Incorporated |
| 14.2.5.Fresenius Medical Care AG & Co. KGaA |
| 14.2.6.NxStage Medical |
| 14.2.7.Poly Medicure Limited |
| 14.2.8.Braun Melsungen AG |
| 15. Research Methodology |
| 16. Appendix and Abbreviations |
Key Market Players
Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthcare domain, encompassing pharmaceuticals, medical devices, and diagnostics. A graduate in Pharmacy, he possesses a strong foundation in the intricacies of the healthcare sector. He further enhanced his expertise by pursuing an MBA in Pharmaceuticals, equipping him with valuable business acumen. His analytical skills and market insights have contributed to strategic decision-making and enhanced market positioning for various healthcare organizations. Committed to driving innovation and excellence, Muni continues to seek opportunities to improve healthcare delivery through data-driven insights.